2022-03-04
Published Date
Healthcare
Industry
108
Pages
Remicade Biosimilar global industry size is estimated to be worth US$XX million in 2022 and is forecast to a readjusted size of US$XX million by 2028 with a CAGR of XX% during the forecast period 2022-2028. Fully considering the economic change by this health crisis (Covid), 100mg/10ml accounting for XX% of the Remicade Biosimilar global market in 2021, is projected to value US$XX million by 2028, growing at a revised XX% CAGR from 2023 to 2028. While Blood Disorders segment is altered to an XX% CAGR throughout this forecast period.
The global key companies of Remicade Biosimilar include Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc., Genentech (Roche Group), Fosun Pharmaceutical, Livzon Pharmaceutical, Anke Biotechnology, Hualan Biological Engineering, Walvax Biotechnology, Hisun Pharmaceutical, etc. In 2022, the global top five players have a share approximately XX% in terms of revenue.
In terms of Production Side,
This report researches the Remicade Biosimilar capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of Sales Side,
This report focuses on the sales of Remicade Biosimilar by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
This research report explores the key market segments: Type and Application. The report offers an in-depth breakdown of type and application segments, and their sub-segments. The growth potential of each segment have been examined by industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments, based on sales, price, and revenue for the period 2017-2028. Additionally, the report features a value chain and raw material analysis of the key segments.
Segment by Type
100mg/10ml
500mg/50ml
Segment by Application
Blood Disorders
Oncology Diseases
The report includes a section on key growth opportunities, which will help the key players to simplify complex issues and frame future strategies to compete in this competitive environment. This section will assist the players to boldly position their business.
Competitive Outlook
This section of the report provides an in-depth analysis of the competitive landscape of the market. The report profiles the key players in the market. It also provides reliable sales and revenue data of the players for the period 2017-2022. With the help of this report, key players, stakeholders, and other participants will be able to stay up-to-date with the recent and upcoming developments in the market, further aiding them in making efficient choices. The prime players profiled in this report are:
Companies
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Note: We can also add companies which are not part of the above list
Global Remicade Biosimilar market: regional analysis, the major regions covered in the report are:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Q: Who are the key players in the Remicade Biosimilar market
A: The key players in the market are Synthon Pharmaceuticals, LG Life Sciences, Novartis (Sandoz), Celltrion, Biocon, Hospira, Merck Serono (Merck Group), Biogen idec Inc., Genentech (Roche Group), Fosun Pharmaceutical, Livzon Pharmaceutical, Anke Biotechnology, Hualan Biological Engineering, Walvax Biotechnology, Hisun Pharmaceutical.
Q: What is the revenue and sales data of the key players of Remicade Biosimilar industry
A: The revenue and sales data of the key players of Remicade Biosimilar industry is mentioned in full report.
Q: What are the recent and upcoming developments in the Remicade Biosimilar market
A: The recent and upcoming developments in the Remicade Biosimilar market are mentioned in this report.
Q: What are the main objectives of the Remicade Biosimilar industry report
A: The main objectives of Remicade Biosimilar industry report are to provide reliable sales and revenue data of the key players and to provide a comprehensive analysis of the competitive landscape.
Q: What are the key highlights of the Remicade Biosimilar market research report
A: The key highlights of Remicade Biosimilar industry report are to help players in decision making, the revenue and sales data of other players, and the recent and upcoming developments in the market.
Q: What is the scope of the Remicade Biosimilar report
A: The Remicade Biosimilar market report covers the market for the period 2017-2028.
Q: What is the methodology of the Remicade Biosimilar report
A: The methodology of Remicade Biosimilar industry report is based on primary and secondary sources.
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Remicade Biosimilar
Figure Global Remicade Biosimilar Market Share by Type in 2021
1.4 By Application
Table Application of Remicade Biosimilar
Figure Global Remicade Biosimilar Market Share by Application in 2021
1.5 By Region
Figure Global Remicade Biosimilar Market Share by Region in 2021
Figure Asia Remicade Biosimilar Market Share by Region in 2021
Part 2 Key Companies
2.1 Synthon Pharmaceuticals
2.1.1 Company Profile
Table Synthon Pharmaceuticals Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Remicade Biosimilar Business Operation of Synthon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 LG Life Sciences
2.3 Novartis (Sandoz)
2.4 Celltrion
2.5 Biocon
2.6 Hospira
2.7 Merck Serono (Merck Group)
2.8 Biogen idec Inc.
2.9 Genentech (Roche Group)
2.10 Fosun Pharmaceutical
2.11 Livzon Pharmaceutical
2.12 Anke Biotechnology
2.13 Hualan Biological Engineering
2.14 Walvax Biotechnology
2.15 Hisun Pharmaceutical
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Remicade Biosimilar Market by Region, 2017-2021 (Million USD)
Figure Global Remicade Biosimilar Market Share by Region in 2021 (Million USD)
Table Global Remicade Biosimilar Market by Region, 2017-2021 (Volume)
Figure Global Remicade Biosimilar Market Share by Region in 2021 (Volume)
Table Price List by Region, 2017-2021
3.2 Global Market by Company
Table Global Remicade Biosimilar Market by Company, 2017-2021 (Million USD)
Figure Global Remicade Biosimilar Market Share by Company in 2021 (Million USD)
Table Global Remicade Biosimilar Market by Company, 2017-2021 (Volume)
Figure Global Remicade Biosimilar Market Share by Company in 2021 (Volume)
Table Price List by Company, 2017-2021
3.3 Global Market by Type
Table Global Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure Global Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table Global Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure Global Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
3.4 Global Market by Application
Table Global Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure Global Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table Global Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure Global Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
3.5 Global Market by Forecast
Figure Global Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Global Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure Asia-Pacific Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure Asia-Pacific Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure Asia-Pacific Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure Asia-Pacific Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure China Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure China Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure China Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Southeast Asia Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Southeast Asia Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure India Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure India Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure India Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Japan Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Japan Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Japan Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Korea Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Korea Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Korea Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Oceania Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Oceania Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure Europe Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table Europe Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure Europe Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
5.2 Europe Market by Application
Table Europe Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure Europe Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table Europe Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure Europe Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Germany Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Germany Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Germany Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure UK Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure UK Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure UK Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure France Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure France Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure France Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Italy Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Italy Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Italy Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Russia Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Russia Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Russia Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Spain Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Spain Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Spain Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Netherlands Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Netherlands Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Turkey Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Turkey Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Switzerland Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Switzerland Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Europe Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure North America Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table North America Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure North America Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
6.2 North America Market by Application
Table North America Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure North America Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table North America Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure North America Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure United States Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure United States Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure United States Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Canada Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Canada Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Canada Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Mexico Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Mexico Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure North America Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure South America Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table South America Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure South America Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
7.2 South America Market by Application
Table South America Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure South America Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table South America Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure South America Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Brazil Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Brazil Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Argentina Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Argentina Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Columbia Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Columbia Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Chile Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Chile Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Chile Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure Peru Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure Peru Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Peru Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure South America Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Remicade Biosimilar Market by Type, 2017-2021 (Million USD)
Figure Middle East & Africa Remicade Biosimilar Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Remicade Biosimilar Market by Type, 2017-2021 (Volume)
Figure Middle East & Africa Remicade Biosimilar Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Remicade Biosimilar Market by Application, 2017-2021 (Million USD)
Figure Middle East & Africa Remicade Biosimilar Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Remicade Biosimilar Market by Application, 2017-2021 (Volume)
Figure Middle East & Africa Remicade Biosimilar Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure GCC Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure GCC Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure GCC Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure North Africa Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure North Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Remicade Biosimilar Market Market Status, 2017-2021 (Million USD)
Figure South Africa Remicade Biosimilar Market Market Status, 2017-2021 (Volume)
Figure South Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Remicade Biosimilar Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
List of Tables and Figures